10x Genomics Inc (STU:1KJ)
€ 12.78 0.095 (0.75%) Market Cap: 1.71 Bil Enterprise Value: 1.41 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 63/100

10X Genomics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 07:50PM GMT
Release Date Price: €149.95 (+1.08%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good afternoon, everyone. I'm Matt Sykes, Senior Research Analyst for Life Science Tools & Diagnostics at Goldman. And I have the pleasure of welcoming the 10x Genomics management team to present to us today. We have Serge Saxonov, the Chief Executive Officer; and Justin McAnear, the Chief Financial Officer. Serge, Justin, thanks so much for being here. We really appreciate it.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thanks for having us. Thank you.

Questions & Answers

Matthew Carlisle Sykes;Serge Saxonov
Goldman Sachs Group, Inc., Research Division - Research Analyst;10x Genomics, Inc. - Co

Maybe I'll turn it over to your first, Serge, to kind of set the stage a little bit, talk about maybe the most recent quarter, expectations for the year, but just also some of the key drivers and things that you want to -- can be top of mind for investors for 10x?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot